A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2019; you can also visit the original URL.
The file type is application/pdf
.
Using a consensus technique for improving the methodology of clinical trials assessing treatments for Cutaneous Leishmaniasis
2015
Trials
Cutaneous Leishmaniasis (CL) is a tropical parasitic disease in humans, transmitted by sandflies. CL causes lesions on exposed parts of the body, potentially leaving life-long scars. The disease manifestations vary significantly, depending on parasite species. An estimated 0.7 -1.3 million new cases occur worldwide annually. Recommendations on the treatment of CL currently have a weak evidence base: not only are treatment options limited, but also have systematic reviews pointed to a lack of
doi:10.1186/1745-6215-16-s2-p59
fatcat:vl6nk2nt5vaavluyyrptgqozaa